News Eledon Pharmaceuticals Appoints Industry Veteran James Robinson to its Board of Directors Continue Reading Previous InflaRx Announces Positive Topline Results from the Single Ascending Dose (SAD) Phase I Study with C5aR Inhibitor INF904Next APRINOIA Therapeutics Announces Strategic Investment From The Alzheimer’s Drug Discovery Foundation (ADDF) Related Stories News Sweet Security Introduces Evolutionary Leap in Cloud Detection and Response, Releasing First Unified Detection & Response Platform News eBRAM Partners with Agency for Volunteer Service to Launch ‘Pro-Bono Online Mediation Scheme for Water Seepage Disputes’ News 15 Companies Pitch Their Capabilities at GA-ASI’s Blue Magic Netherlands News Advancing the Belt and Road Initiative: The Kyrgyz Republic Ministry of Finance’s First Promotional Seminar and Non-Deal Roadshow Successfully Held News #CTS24 Concluded Last Week, Advancing Net-Zero Goals and Sustainable Solutions News China Medical System Gained Exclusive Commercialization Right of Class 1 Innovative Drug Targeting Gout and Hyperuricemia
